Latest news
SHY Therapeutics Doses First Patient in SHY-ONC6 Phase 1 Trial for Solid Tumors - The Clinical Trial VanguardThe Clinical Trial Vanguard · Wed, 05 Aug 2026 06:48:36 GMTModerna vaccinates first participants in trial for Ebola strain with no vaccine - Stock TitanStock Titan · Tue, 04 Aug 2026 15:00:00 GMTCREATE Medicines Receives Approval to Initiate First-in-Human Phase 1/2 Clinical Trial of In Vivo CAR-T Candidate CRT-402 for Autoimmune Diseases - PR NewswirePR Newswire · Thu, 30 Jul 2026 07:00:00 GMTStartup advances novel oral Type 1 diabetes therapy to next phase of human testing - The University of Alabama at BirminghamThe University of Alabama at Birmingham · Wed, 29 Jul 2026 07:00:00 GMTAccelerating and Modernizing Early and Late-Stage Clinical Development - fda.govfda.gov · Mon, 27 Jul 2026 07:00:00 GMT[Press release] Atea Pharmaceuticals initiates first-in-human Phase 1 clinical trial of AT-587 for the treatment of hepatitis E virus - European AIDS Treatment GroupEuropean AIDS Treatment Group · Sun, 26 Jul 2026 23:26:08 GMT